CN Patent

CN111362946A — 一种药物化合物及其组合物和应用

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2020-07-03 · 6y expired

What this patent protects

本发明提供的新化合物显示出的生物活性，可用作TRK激酶抑制剂，如用于治疗TRK介导的疾病或病症的药物癌症、皮炎或哮喘等的治疗和预防。

USPTO Abstract

本发明提供的新化合物显示出的生物活性，可用作TRK激酶抑制剂，如用于治疗TRK介导的疾病或病症的药物癌症、皮炎或哮喘等的治疗和预防。

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: CN111362946A
Jurisdiction: CN
Classification: —
Expires: 2020-07-03
Drug substance claim: No
Drug product claim: No
Assignee: Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.